
Course program
Review all the speakers and their topics, divided into 3 days of activity. Organized by day and thematic working session.
Day 1: Introduction to Neurepiomics
21/10
Session 1: Introduction
Dr.Hieab Adams (Chile & Netherlands)
9:00-9:05 Welcome
Prof. Lenore Launer (US)
9:05-9:35 Epidemiology of stroke and dementia
Prof. Sudha Seshadri (US)
9:40-10:10 (Gen)omics of dementia and imaging endophenotypes
Prof. Stephanie Debette (France)
10:15-10:45 (Gen)omics of stroke and MRI-markers of cerebral small vessel disease
10:45 – 11:00 Coffee break
Session 2: Genome wide association studies
Dr. Aniket Mishra (France)
11:00-11:30 Introduction to methodological approaches for GWAS and WGS, with practical tutorial
Dr. Myriam Fornage (US)
11:35- 12:05 Leveraging population diversity and admixture for genomic and multiomic studies
Dr.Alfredo Ramírez (Germany and Chile)
12:10-12:40 (Gen)omics of brain disease in non-European ancestry populations
12:45 – 14:10 Lunch
Session 3: Unraveling brain phenotypes
Dr. Tomas Paus (Canada)
14:15-14:45 From virtual histology to novel brain imaging phenotypes for omics of brain disease
Dr. Olivier Colliot (France):
14:50-15:20 AI/ML approaches to leverage very large-scale clinic-based brain MRI resources
Dr. Ami Tsuchida(France):
16:15-16:40 AI/ML approaches to derive comprehensive MRI-markers of cerebral small vessel disease
16:00 – 16:15 Coffee break
Session 4: Mechanisms in neurodegeneration
Prof. Claudia Duran Aniotz (Chile)
16:15-16:45 Blood biomarkers in AD: status quo in LA
Dr. Claudia Satizabal (Chile)
16:50-17:20 Vascular mechanisms in neurodegeneration: the MarkVCID consortium
Dr. Jacobo Diego Sitt (France)
17:25-17:55 Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness
18:30 – 22:30 Group dinner
Day 2: (Gen)omics of brain disease in non-European ancestry populations
22/10
Session 5: Neurodegeneration in diverse groups
Dr. Tavia Evans (Ireland)
9:05-9:30 A global perspective on neurodegeneration: barriers and solutions to more representative research
Prof. Agustín Ibanez (Chile)
9:35-10:05 Multimodal diversity, biophysical modeling, brain clocks, and higher-order interactions in aging and dementia
Dr. Sarael Alcauter (Mex)
10:10-10:40 MexPD: genes, mental health, and brain function in Parkinson's Disease in Mexico
10:45 – 11:00 Coffee break
Session 6: Stroke in diverse groups
Prof. Rufus Akinyemi (Nigeria)
11:00-11:30 African Stroke Organization and first indigenous African GWAS, African Dementia Network
Prof. Hee-Joon Bae (Korea)
11:35-12:05 GENESIS-K, towards a global vascular brain health initiative in East-Asia
Prof. Guido Falcone (US)
12:10-12:40 Unraveling stroke mechanisms and risk factors in diverse populations using genomics in the All of Us study
Dr. Leslie Ecker-Ferreira (Brazil)
12:45-13:15 Contributions of the Joinville Stroke Biobank to Stroke Genetics Research in Brazil
13:20 – 14:35 Lunch
15:30 – 17:00 BrainLat tour + group picture (including transportation)
17:00 – 21:00 Social event and dinner (including transportation)
Day 3: Cutting edge technologies
23/10
Session 7: Emerging techniques
Dr. Phil de Jager (US)
9:05-9:30 Modeling single nucleus data to reconstruct the sequence of cellular events leading to Alzheimer’s disease
Dr. Hieab Adams (Nederland and Chile)
9:35-10:05 Deciphering cell death in vivo using cell-free DNA methylation
Dr. Joshua Harper (Paraguay)
10:10-10:40 Engineering an ultra-low-field MRI for brain research
10:45 – 11:00 Coffee break
Session 8: Low-field imaging spotlight
Dr. Jean-Michel Franconi (France)
11:00-11:30 Opportunities and challenges of low-field MRI – a physicist’s perspective
Dr. Philippe Massot (France)
11:35-12:05 Opportunities and challenges of low-field MRI – a physicist’s perspective
Dr. Pablo Irarrazaval (Chile)
12:10-12:40 Challenges of imaging at low field: sequences and reconstruction
Dr. Carolina Ochoa Rosales (Chile)
12:45-13:15 Utilizing ultra-low-field imaging in research and clinical practice
13:30 – 14:45 Lunch
End of Neurepiomics